Pozas, J.; Cheruvu, S.; Jaganathan, P.P.; Ganesan, P.; Modi, A.; Larkin, J.; Cossar, L.; Olsson-Brown, A.; Johnson, A.; Garbutt, N.;
et al. Late-Onset Immune-Related Adverse Events in Patients with Advanced Melanoma: The LATENT Study. Cancers 2025, 17, 2461.
https://doi.org/10.3390/cancers17152461
AMA Style
Pozas J, Cheruvu S, Jaganathan PP, Ganesan P, Modi A, Larkin J, Cossar L, Olsson-Brown A, Johnson A, Garbutt N,
et al. Late-Onset Immune-Related Adverse Events in Patients with Advanced Melanoma: The LATENT Study. Cancers. 2025; 17(15):2461.
https://doi.org/10.3390/cancers17152461
Chicago/Turabian Style
Pozas, Javier, Sowmya Cheruvu, Poorni Priya Jaganathan, Priya Ganesan, Arjun Modi, James Larkin, Laura Cossar, Anna Olsson-Brown, Alexandra Johnson, Nicholas Garbutt,
and et al. 2025. "Late-Onset Immune-Related Adverse Events in Patients with Advanced Melanoma: The LATENT Study" Cancers 17, no. 15: 2461.
https://doi.org/10.3390/cancers17152461
APA Style
Pozas, J., Cheruvu, S., Jaganathan, P. P., Ganesan, P., Modi, A., Larkin, J., Cossar, L., Olsson-Brown, A., Johnson, A., Garbutt, N., Lee, R., Jones, J., Macklin-Doherty, A., Young, K., & LATENT Study Investigators.
(2025). Late-Onset Immune-Related Adverse Events in Patients with Advanced Melanoma: The LATENT Study. Cancers, 17(15), 2461.
https://doi.org/10.3390/cancers17152461
